Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 8, 2004, Pages 910-915

  Numata, Yoshihiro ^a   Tazuma, Susumu ^a   Nishioka, Tomoji ^a   Ueno, Yoshitaka ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Dextran sulfate sodium; Natural killer T cells; Primary sclerosing cholangitis; Th1 cells; Ulcerative cholitis

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL POPULATION; CHOLANGITIS; COLITIS; COLON; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FLOW CYTOMETRY; HEPATOBILIARY DISEASE; IMMUNE RESPONSE; LEUKOCYTE COUNT; LIVER HISTOLOGY; LIVER NECROSIS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 4143124293     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03333.x     Document Type: Article

References (20)

1. Kono K, Ohnishi K, Omata M et al. Experimental portal fibrosis produced by intraportal injection of killed non-pathogenic Escherichia coli in rabbits. Gastroenterology 1988; 94: 787-96.
2. Ueno Y, Phillips JQ, Ludwig J, Lichtman SN, LaRusso NF. Development and characterization of a rodent model of immune-mediated cholangitis. Proc. Natl Acad. Sci. USA 1996; 93: 216-20.
3. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
4. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
5. Watanabe H, Ohtsuka K, Kimura M et al. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods 1992; 146: 145-54.
6. Lefrancois L, Lycke N. Isolation of mouse small intestinal IEL, Peyer's patch, and lamina propria cells. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: John Wiley and Sons, 1996, 1-16.
7. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240-8.
8. Krieglstein CF, Cerwinka WH, Laroux FS et al. Role of appendix and spleen in experimental colitis. J. Surg. Res. 2001; 101: 166-75.
9. Bertolotti A, Wang X, Novoa I et al. Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice. J. Clin. Invest. 2001; 107: 585-93.
10. Kitajima S, Takuma S, Morimoto M. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp. Anim. 2000; 49: 9-15.
11. Boberg KM, Lundin KEA, Schrumpf E. Etiology and pathogenesis in primary screlosing cholangitis. Scand. J. Gastroenterol. 1994; 29 (Suppl. 204): 47-58.
12. Dienes HP, Lohse AW, Gerken G et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch. 1997; 431: 119-24.
13. Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 2001; 166: 6012-18.
14. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 2000; 192: 921-30.
15. Takeda K, Hayakawa Y, Kaer LV, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl Acad. Sci. USA 2000; 97: 5498-503.
16. Toyabe S, Seki S, Iiai T et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 1997; 159: 1537-42.
17. Saubermann LJ, Beck P, De Jong YP et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000; 119: 119-28.
18. Vierling JM. Animal models for primary sclerosing cholangitis. Best Pract. Res. Clin. Gastroenterol. 2001; 15: 591-610.
19. Orth T, Neurath M, Schirmacher P, Galle PR, Mayet WJ. A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies. J. Hepatol. 2000; 33: 862-72.
20. Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991; 13: 766-72.